Longeveron (LGVN) Other Working Capital Changes (2020 - 2026)
Longeveron (LGVN) posted quarterly Other Working Capital Changes of $11000.0 for Q1 2026, down 82.81% year-over-year from $64000.0 in Q1 2025, and down 82.54% quarter-over-quarter from $63000.0 in Q4 2025.
Longeveron (LGVN) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Longeveron's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $11000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 82.81% year-over-year to $11000.0; the TTM figure through Mar 2026 stood at $201000.0 (down 21.18% YoY), while the FY2025 annual figure was $254000.0, changed 0.0% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $11000.0, down from $63000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $912000.0 in Q1 2024, with the low at -$901000.0 in Q2 2024.
- The 5-year median for Other Working Capital Changes is -$1000.0 (2024), against an average of -$2294.1.
- The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes gained 25.49% in 2024, then sank 82.81% in 2026.
- Longeveron's Other Working Capital Changes stood at $64000.0 in 2023, then retreated by 1.56% to $63000.0 in 2024, then changed by 0.0% to $63000.0 in 2025, then tumbled by 82.54% to $11000.0 in 2026.
- Business Quant data shows LGVN's Other Working Capital Changes at $11000.0 in Q1 2026, $63000.0 in Q4 2025, and $64000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Longeveron | 26.51 Mn | 16.41 Mn | 182,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 152,000.00 |
| Jun 30, 2026 | 152,000.00 |
| Jun 30, 2026 | 152,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Dec 31, 2025 | -236,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Jun 30, 2025 | -14,000.00 |
| Mar 31, 2025 | 610,000.00 |
| Mar 31, 2025 | 610,000.00 |
| Mar 31, 2025 | 610,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Dec 31, 2024 | -476,000.00 |